In PCa cells, as well as in patient-derived prostate tumor explants, MET/VPA combination synergistically inhibited proliferation and induced apoptosis in a P53- and AR-dependent manner, without significantly affecting normal Prostate Epithelial Cells (PrEC) [155]. Here, AR is linked to posterior cortical atrophy.